Delivery Order SPE2DB20D2104-SPE2DB25FMXLY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors, with a contract ceiling value of $5,466.66 and an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,260.85 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on August 1, 2025, with completion scheduled for August 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.13 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections (0.5 ml). This firm fixed-price delivery order, with a completion date of August 8, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,938.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with a completion date of August 8, 2025. This non-competitive, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,410.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $3,156.24. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXLYDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,556.56 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The product will be performed and delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal medical systems worldwide. The prime contract reflects DLA's strategic pharmaceutical procurement approach and AmerisourceBergen's established capability as a major pharmaceutical distributor serving Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/11/25 |